Bellevue Life Sciences Acquisition Corp. Business Finance Contracts & Agreements
42 Contracts & Agreements
- Escrow Agreements (4 contracts)
- Joinder Agreements (2)
- Note Agreements (2)
- Purchase Agreements (6)
- Registration Rights Agreements (5)
- Stock Agreements (8)
- Subscription Agreements (2)
- Underwriting Agreements (4)
- Warrant Agreements (9)
- Promissory Note, dated November 13, 2023, issued by Bellevue Life Sciences Acquisition Corp. to Bellevue Capital Management LLC (Filed With SEC on November 16, 2023)
- Form of Non-Participating Stockholder Joinder Agreement (Filed With SEC on November 16, 2023)
- Form of Participating Stockholder Joinder Agreement (Filed With SEC on November 16, 2023)
- Promissory Note, dated June 23, 2023, issued by Bellevue Life Sciences Acquisition Corp. to Bellevue Global Life Sciences Investors LLC (Filed With SEC on June 28, 2023)
- Stock Escrow Agreement, dated February 9, 2023, by and among the Company, the Sponsor, and Company and Continental Stock Transfer & Trust Company (Filed With SEC on February 15, 2023)
- Amended and Restated Placement Unit Purchase Agreement, dated February 9, 2023, by and between the Company and the Sponsor (Filed With SEC on February 15, 2023)
- Registration Rights Agreement, dated February 9, 2023, by and among the Company and certain security holders (Filed With SEC on February 15, 2023)
- Investment Management Trust Agreement, dated February 7, 2023, by and between the Company and Continental Stock Transfer & Trust Company (Filed With SEC on February 15, 2023)
- Rights Agreement, dated February 9, 2023, by and between Continental Stock Transfer & Trust Company and the Company (Filed With SEC on February 15, 2023)
- Warrant Agreement, dated February 9, 2023, by and between Continental Stock Transfer & Trust Company and the Company (Filed With SEC on February 15, 2023)
- Underwriting Agreement, dated February 9, 2023, by and between the Company and Chardan. as representative of the underwriters (Filed With SEC on February 15, 2023)
- Form of Stock Escrow Agreement by and among Bellevue Life Sciences Acquisition Corp., Continental Stock Transfer & Trust Company, and Bellevue Global Life Sciences Investors, LLC (Filed With SEC on January 20, 2023)
- Form of Amended and Restated Placement Unit Purchase Agreement between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on January 20, 2023)
- Form of Registration Rights Agreement between the Registrant and certain security holders (Filed With SEC on January 20, 2023)
- Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on January 20, 2023)
- Form of Rights Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on January 20, 2023)
- Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on January 20, 2023)
- Form of Underwriting Agreement (Filed With SEC on January 20, 2023)
- Amended and Restated Placement Unit Purchase Agreement, dated November 4, 2022, between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on November 4, 2022)
- Form of Stock Escrow Agreement by and among Bellevue Life Sciences Acquisition Corp., Continental Stock Transfer & Trust Company, and Bellevue Global Life Sciences Investors, LLC (Filed With SEC on October 7, 2022)
- Amended and Restated Placement Unit Purchase Agreement, dated , 2022, between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on October 7, 2022)
- Form of Registration Rights Agreement between the Registrant and certain security holders (Filed With SEC on October 7, 2022)
- Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on October 7, 2022)
- Form of Rights Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on October 7, 2022)
- Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on October 7, 2022)
- Form of Underwriting Agreement (Filed With SEC on October 7, 2022)
- Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on May 13, 2022)
- Specimen Warrant Certificate (Filed With SEC on May 13, 2022)
- Placement Unit Purchase Agreement, dated April 25, 2022, between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on May 10, 2022)
- Amended and Restated Securities Subscription Agreement, dated April 22, 2022, between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on May 10, 2022)
- Form of Registration Rights Agreement between the Registrant and certain security holders (Filed With SEC on May 10, 2022)
- Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on May 10, 2022)
- Specimen Warrant Certificate (Filed With SEC on May 10, 2022)
- Form of Underwriting Agreement (Filed With SEC on May 10, 2022)
- Form of Stock Escrow Agreement by and among Bellevue Life Sciences Acquisition Corp., Continental Stock Transfer & Trust Company, and Bellevue Global Life Sciences Investors, LLC (Filed With SEC on April 29, 2022)
- Placement Unit Purchase Agreement, dated April 25, 2022, between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on April 29, 2022)
- Amended and Restated Securities Subscription Agreement, dated April 22, 2022, between the Registrant and Bellevue Global Life Sciences Investors LLC (Filed With SEC on April 29, 2022)
- Form of Registration Rights Agreement between the Registrant and certain security holders (Filed With SEC on April 29, 2022)
- Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on April 29, 2022)
- Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on April 29, 2022)